Evidence map›Paper›PMID 25811984›Full record

ArticlePloS one2015

S100A8/A9 stimulates keratinocyte proliferation in the development of squamous cell carcinoma of the skin via the receptor for advanced glycation-end products.

Guergana Iotzova-Weiss, Piotr J Dziunycz, Sandra N Freiberger, Severin Läuchli, Jürg Hafner, Thomas Vogl, Lars E French, Günther F L Hofbauer

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. RAGE Inhibitors for Targeted Therapy of Cancer: A Comprehensive Review.International journal of molecular sciences · 2022
    Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Oncology letters · 2018
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Guergana Iotzova-WeissDepartment of Dermatology, University Hospital Zurich, Zurich, Switzerland.
Piotr J DziunyczDepartment of Dermatology, University Hospital Zurich, Zurich, Switzerland.
Sandra N FreibergerDepartment of Dermatology, University Hospital Zurich, Zurich, Switzerland.
Severin LäuchliDepartment of Dermatology, University Hospital Zurich, Zurich, Switzerland.
Jürg HafnerDepartment of Dermatology, University Hospital Zurich, Zurich, Switzerland.
Thomas VoglInstitute of Immunology, University Clinic Münster, Münster, Germany.
Lars E FrenchDepartment of Dermatology, University Hospital Zurich, Zurich, Switzerland.
Günther F L HofbauerDepartment of Dermatology, University Hospital Zurich, Zurich, Switzerland.
University Hospital of Zurich · CHUniversity Hospital Münster · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Squamous cell carcinoma (SCC) is the most common neoplasm in organ transplant recipients (OTR) on long-term immunosuppression and occurs 60- to 100-fold more frequently than in the general population. Here, we present the receptor for advanced glycation end products (RAGE) and S100A8/A9 as important factors driving normal and tumor keratinocyte proliferation. RAGE and S100A8/A9 were transcriptionally upregulated in SCC compared to normal epidermis, as well as in OTR compared to immunocompetent patients (IC) with SCC. The proliferation of normal and SCC keratinocytes was induced by exposure to exogenous S100A8/A9 which in turn was abolished by blocking of RAGE. The migratory activities of normal and SCC keratinocytes were also increased upon exposure to S100A8/A9. We demonstrated that exogenous S100A8/A9 induces phosphorylation of p38 and SAPK/JNK followed by activation of ERK1/2. We hypothesize that RAGE and S100A8/A9 contribute to the development of human SCC by modulating keratinocyte growth and migration. These processes do not seem to be impaired by profound drug-mediated immunosuppression in OTR.

Indexed as

Calgranulin ACalgranulin BCarcinoma, Squamous CellCell MovementCell ProliferationCell Transformation, NeoplasticGene ExpressionGene Expression Regulation, NeoplasticGene Knockdown TechniquesHumansKeratinocytesPhosphorylationReceptor for Advanced Glycation End ProductsSignal TransductionSkin NeoplasmsAGER protein, humanCalgranulin ACalgranulin BReceptor for Advanced Glycation End Products

Identifiers

PMID25811984
PMCPMC4374726
OpenAlexW2047163663

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.